HIV Policy & Advocacy
Death Rates Decline in African Countries Receiving PEPFAR Funding
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 18 May 2012 00:00
- Written by Liz Highleyman
More than 740,000 deaths may have been prevented in African countries that received intensive aid through the President’s Emergency Plan for AIDS Relief, better known as PEPFAR, according to a new analysis of more than 1.5 million people published in the May 16, 2012, Journal of the American Medical Association (JAMA).
Institute of Medicine Releases Report on Monitoring HIV Care
- Details
- Category: HIV Treatment
- Published on Tuesday, 03 April 2012 00:00
- Written by IOM
In March the Institute of Medicine (IOM) issued a report commissioned by the Office of National AIDS Policy that recommends standardized indicators for monitoring use of clinical services by people with HIV/AIDS.
HIV Physician Urge Supreme Court to Uphold Health Care Reform
- Details
- Category: HIV Policy & Advocacy
- Published on Tuesday, 27 March 2012 00:00
- Written by Press Release
On March 26 the Supreme Court began hearing arguments in a lawsuit challenging provisions of the Patient Protection and Affordable Care Act, Obama's controversial health insurance reform plan. The HIV Medicine Association and Lambda Legal urged the court to retain the individual mandate, arguing that health reform is essential for people with HIV/AIDS.
ACT UP at 25
- Details
- Category: HIV Policy & Advocacy
- Published on Tuesday, 27 March 2012 00:00
- Written by Liz Highleyman
The AIDS Coalition to Unleash Power, better known as ACT UP, held its first major action -- a demonstration on Wall Street demanding access to experimental HIV drugs and an end to discrimination against people with AIDS -- on March 24, 1987. The group's eye-catching graphics and savvy use of the media received widespread attention, and soon ACT UP chapters were springing up across the U.S. and around the world.
Federal Syringe Access Policy: Where Are We Now?
- Details
- Category: Injection Drug Use
- Published on Tuesday, 20 March 2012 00:00
- Written by Matt Sharp
Late last year Congress voted to reinstate a ban on federal funding for syringe exchange programs, which had only been repealed in 2009 after 2 decades of concerted advocacy by harm reduction and HIV and hepatitis prevention activists. Matt Sharp talked with Laura Thomas, the Drug Policy Alliance's Interim State Director for California and a long-time needle exchange volunteer, about the status of syringe access in the U.S. and where do we go from here.
